Tyche Wealth Partners LLC Novartis Ag Transaction History
Tyche Wealth Partners LLC
- $570 Billion
- Q3 2025
A detailed history of Tyche Wealth Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 2,250 shares of NVS stock, worth $295,987. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,250
Previous 2,250
-0.0%
Holding current value
$295,987
Previous $272 Million
5.97%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,610Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...